Co-Authors
This is a "connection" page, showing publications co-authored by Mario Cozzolino and Antonio Bellasi.
Connection Strength
3.773
-
Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide. Ther Clin Risk Manag. 2017; 13:679-689.
Score: 0.719
-
[CKD-MBD, cardiovascular involvement and prognosis]. G Ital Nefrol. 2017 Mar; 34(Suppl 69):150-161.
Score: 0.706
-
Vitamin D Metabolism and Potential Effects of Vitamin D Receptor Modulation in Chronic Kidney Disease. Curr Drug Metab. 2017; 18(7):680-688.
Score: 0.698
-
Cinacalcet: the chemical parathyroidectomy? Clin Kidney J. 2013 Jun; 6(3):253-6.
Score: 0.545
-
Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options. Cardiorenal Med. 2019; 9(1):8-21.
Score: 0.198
-
[New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy]. G Ital Nefrol. 2018 May; 35(3).
Score: 0.191
-
Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease. Expert Rev Clin Pharmacol. 2017 Oct; 10(10):1073-1084.
Score: 0.183
-
The treatment of type 2 diabetes mellitus in patients with chronic kidney disease: What to expect from new oral hypoglycemic agents. Diabetes Metab Syndr. 2017 Nov; 11 Suppl 1:S295-S305.
Score: 0.177
-
[Newer anti - diabetic therapies and chronic kidney disease]. G Ital Nefrol. 2017 Jan-Feb; 34(1).
Score: 0.175
-
[Clinical practice for the diagnosis of cardiac arrhythmias in patients on renal replacement therapy: data from a Lombard survey]. G Ital Nefrol. 2017 Dec 05; 34(Nov-Dec).
Score: 0.047
-
[Neprilysin inhibition and chronic kidney disease]. G Ital Nefrol. 2017 Sep 28; 34(5):102-112.
Score: 0.046
-
[Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation]. G Ital Nefrol. 2017 Apr; 34(2):58-73.
Score: 0.044
-
[NOACs and Chronic kidney disease]. G Ital Nefrol. 2017 Mar; 34(Suppl 69):188-204.
Score: 0.044